288 related articles for article (PubMed ID: 31319131)
1. AMPK as a potential pharmacological target for alleviating LPS-induced acute lung injury partly via NLRC4 inflammasome pathway inhibition.
He Y; Xu K; Wang Y; Chao X; Xu B; Wu J; Shen J; Ren W; Hu Y
Exp Gerontol; 2019 Oct; 125():110661. PubMed ID: 31319131
[TBL] [Abstract][Full Text] [Related]
2. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis.
Liu Y; Zhang Y; You G; Zheng D; He Z; Guo W; Antonina K; Shukhrat Z; Ding B; Zan J; Zhang Z
Inflamm Res; 2024 Jan; 73(1):47-63. PubMed ID: 38147126
[TBL] [Abstract][Full Text] [Related]
3. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
6. Buformin alleviates sepsis-induced acute lung injury via inhibiting NLRP3-mediated pyroptosis through an AMPK-dependent pathway.
Liu B; Wang Z; He R; Xiong R; Li G; Zhang L; Fu T; Li C; Li N; Geng Q
Clin Sci (Lond); 2022 Feb; 136(4):273-289. PubMed ID: 35132999
[TBL] [Abstract][Full Text] [Related]
7. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H
J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449
[TBL] [Abstract][Full Text] [Related]
8. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Meng S; Xian H; Che H; Lv J; Li Y; Yu Y; Bai Y; Wang L
Int J Biol Sci; 2019; 15(5):1010-1019. PubMed ID: 31182921
[TBL] [Abstract][Full Text] [Related]
9. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
[TBL] [Abstract][Full Text] [Related]
12. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
[TBL] [Abstract][Full Text] [Related]
13. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
[TBL] [Abstract][Full Text] [Related]
15. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
Lu Y; Yu T; Liu J; Gu L
PLoS One; 2018; 13(4):e0196405. PubMed ID: 29694408
[TBL] [Abstract][Full Text] [Related]
16. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3.
Liao H; Zhang S; Qiao J
Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284
[TBL] [Abstract][Full Text] [Related]
17. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.
Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN
Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915
[TBL] [Abstract][Full Text] [Related]
18. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-delivered angiopoietin-1 ameliorates phosgene-induced acute lung injury via inhibition of NLRP3 inflammasome activation.
He DK; Chen JF; Shao YR; Zhou FQ; Shen J
Inhal Toxicol; 2018; 30(4-5):187-194. PubMed ID: 30257148
[TBL] [Abstract][Full Text] [Related]
20. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
Yang H; Lv H; Li H; Ci X; Peng L
Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
